• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Health Indicators in Hospitalized Patients With SARS-CoV-2 Pneumonia: A Comparison Between the First and Second Wave.

作者信息

Rodríguez-Núñez Nuria, Gude Francisco, Lama Adriana, Rábade Carlos, Varela Alfonso, Abelleira Romina, Casal Ana, Riveiro Vanessa, Taboada Manuel, Pose Antonio, Valdés Luis

机构信息

Pulmonology Department, University Clinical Hospital of Santiago, Santiago de Compostela, Spain.

Epidemiology Department, Research Methods Group, University Clinical Hospital of Santiago, Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.

出版信息

Arch Bronconeumol. 2021 Nov;57(11):717-719. doi: 10.1016/j.arbr.2021.03.019. Epub 2021 Nov 1.

DOI:10.1016/j.arbr.2021.03.019
PMID:34744252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8558389/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc9a/8558389/c6791702e72b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc9a/8558389/c6791702e72b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc9a/8558389/c6791702e72b/gr1_lrg.jpg

相似文献

1
Health Indicators in Hospitalized Patients With SARS-CoV-2 Pneumonia: A Comparison Between the First and Second Wave.新型冠状病毒肺炎住院患者的健康指标：第一波与第二波的比较
Arch Bronconeumol. 2021 Nov;57(11):717-719. doi: 10.1016/j.arbr.2021.03.019. Epub 2021 Nov 1.
2
Health Indicators in Hospitalized Patients With SARS-CoV-2 Pneumonia: A Comparison Between the First and Second Wave.新型冠状病毒肺炎住院患者的健康指标：第一波与第二波的比较
Arch Bronconeumol (Engl Ed). 2021 Mar 23. doi: 10.1016/j.arbres.2021.03.012.
3
Health Indicators in Hospitalized Patients With SARS-CoV-2 Pneumonia: A Comparison Between the First and Second Wave.新型冠状病毒肺炎住院患者的健康指标：第一波与第二波的比较
Arch Bronconeumol. 2021 Nov;57(11):717-719. doi: 10.1016/j.arbres.2021.03.012. Epub 2021 Mar 23.
4
International Changes in COVID-19 Clinical Trajectories Across 315 Hospitals and 6 Countries: Retrospective Cohort Study.国际 315 家医院 6 个国家 COVID-19 临床转归变化：回顾性队列研究。
J Med Internet Res. 2021 Oct 11;23(10):e31400. doi: 10.2196/31400.
5
Clinical Presentation and Outcome of Hospitalized Patients With COVID-19 in the First and Second Waves in Saudi Arabia.沙特阿拉伯第一波和第二波 COVID-19 住院患者的临床表现和结局。
Int J Infect Dis. 2022 May;118:104-108. doi: 10.1016/j.ijid.2022.02.048. Epub 2022 Feb 25.
6
Pneumonia in Hospitalized Children During SARS-CoV-2 Pandemic. Is it All COVID-19? Comparison Between COVID and Non-COVID Pneumonia.SARS-CoV-2 大流行期间住院儿童肺炎。都是 COVID-19 吗？COVID 与非 COVID 肺炎的比较。
Pediatr Infect Dis J. 2021 Mar 1;40(3):e111-e113. doi: 10.1097/INF.0000000000003008.
7
Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria.早期识别低风险 SARS-CoV-2 肺炎：基于初始数据和美国传染病学会/美国胸科学会次要标准验证的模型。
Chest. 2022 Oct;162(4):768-781. doi: 10.1016/j.chest.2022.05.013. Epub 2022 May 21.
8
Impact of Hyperglycemia on Cardiovascular Events and Clinical Outcomes in Patients Hospitalized With COVID-19 Pneumonia.高血糖对 COVID-19 肺炎住院患者心血管事件和临床结局的影响。
Endocr Pract. 2022 Aug;28(8):780-786. doi: 10.1016/j.eprac.2022.05.011. Epub 2022 Jun 4.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
Comparison between SARS-CoV-2 positive and negative pneumonia in children: A retrospective analysis at the beginning of the pandemic.儿童新冠病毒阳性与阴性肺炎的比较：大流行初期的回顾性分析
World J Exp Med. 2022 Mar 20;12(2):26-35. doi: 10.5493/wjem.v12.i2.26.

引用本文的文献

1
Evolution of the pandemic: Analysis of demographic characteristics of COVID-19-infected patients during its two waves in Gwalior district of central India.疫情演变：印度中部瓜廖尔地区新冠疫情两波期间新冠病毒感染患者的人口统计学特征分析
J Family Med Prim Care. 2022 Apr;11(4):1314-1321. doi: 10.4103/jfmpc.jfmpc_1189_21. Epub 2022 Mar 18.

本文引用的文献

1
Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic.美国在大流行的前 6 个月中，因 COVID-19 入院的患者的医院死亡率存在差异。
JAMA Intern Med. 2021 Apr 1;181(4):471-478. doi: 10.1001/jamainternmed.2020.8193.
2
Development and validation of a clinical score to estimate progression to severe or critical state in COVID-19 pneumonia hospitalized patients.开发和验证一种临床评分，以估计 COVID-19 肺炎住院患者向严重或危急状态进展的可能性。
Sci Rep. 2020 Nov 13;10(1):19794. doi: 10.1038/s41598-020-75651-z.
3
Trends in COVID-19 Risk-Adjusted Mortality Rates.
COVID-19 风险调整死亡率趋势。
J Hosp Med. 2021 Feb;16(2):90-92. doi: 10.12788/jhm.3552.
4
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
5
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study.COVID-19 所致急性呼吸衰竭未插管患者俯卧位通气的可行性和生理影响（PRON-COVID）：一项前瞻性队列研究。
Lancet Respir Med. 2020 Aug;8(8):765-774. doi: 10.1016/S2213-2600(20)30268-X. Epub 2020 Jun 19.
6
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
7
Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19.开发和验证一种临床风险评分，以预测 COVID-19 住院患者发生危重症的情况。
JAMA Intern Med. 2020 Aug 1;180(8):1081-1089. doi: 10.1001/jamainternmed.2020.2033.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Guidelines for the management of adult lower respiratory tract infections--summary.成人下呼吸道感染管理指南——概述。
Clin Microbiol Infect. 2011 Nov;17 Suppl 6:1-24. doi: 10.1111/j.1469-0691.2011.03602.x.